Center Overview The mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases. The DRC accomplishes this mission through Biomedical Research Core services reflecting the evolving needs of diabetes investigators, vibrant Pilot & Feasibility Programs, and a dynamic Enrichment Program. Now in its 40th year of continuous NIDDK funding, this DRC is located at an outstanding research institution with a longstanding tradition of excellence in diabetes investigation. The WUSM DRC Research Base is organized in four Focus Groups: Metabolic Regulation, Islet Biology & Immunology, Prevention & Epidemiology, and Complications. Investigators from each group participate in DRC programs that address the Center's central scientific theme of enhancing approaches across the translational spectrum. There is compelling evidence that the WUSM DRC is successfully pursuing its mission of supporting and enhancing research, including outstanding productivity as measured by both by scientific publications and peer-reviewed funding in diabetes and related research. Our research strategy will build on these accomplishments by: 1. Creating an environment that supports important as well as innovative research in diabetes and related metabolic disorders; 2. Supporting cutting edge basic and clinical research related to the etiology, pathogenesis, prevention and cure of diabetes; 3. Raising awareness and interest in fundamental and clinical diabetes research in addition to enhancing multidisciplinary approaches to diabetes and its complications; and 4. Translating new knowledge in diabetes to improved treatment of patients with diabetes.
Center Overview Diabetes and related metabolic disorders of obesity, insulin resistance, and metabolic syndrome are complex, systemic conditions involving environmental and genetic influences. The infrastructure and support of the Washington University DRC, as well as its nurturing and collaborative nature, are designed to foster multidisciplinary approaches across the translational spectrum to achieve progress in understanding the pathophysiology of these disorders and in developing an infrastructure for developing new treatments, cures and preventive strategies for diabetes and its complications.
|Colleluori, Georgia; Chen, Rui; Napoli, Nicola et al. (2018) Fat Mass Follows a U-Shaped Distribution Based on Estradiol Levels in Postmenopausal Women. Front Endocrinol (Lausanne) 9:315|
|Liss, Kim H H; McCommis, Kyle S; Chambers, Kari T et al. (2018) The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury. Liver Transpl 24:908-921|
|Liss, Kim H H; Lutkewitte, Andrew J; Pietka, Terri et al. (2018) Metabolic importance of adipose tissue monoacylglycerol acyltransferase 1 in mice and humans. J Lipid Res 59:1630-1639|
|Yoshino, Jun; Almeda-Valdes, Paloma; Moseley, Anna C et al. (2018) Percutaneous muscle biopsy-induced tissue injury causes local endoplasmic reticulum stress. Physiol Rep 6:e13679|
|Evans, Trent D; Jeong, Se-Jin; Zhang, Xiangyu et al. (2018) TFEB and trehalose drive the macrophage autophagy-lysosome system to protect against atherosclerosis. Autophagy 14:724-726|
|Lin, Meei-Hua; Miller, Joseph B; Kikkawa, Yamato et al. (2018) Laminin-521 Protein Therapy for Glomerular Basement Membrane and Podocyte Abnormalities in a Model of Pierson Syndrome. J Am Soc Nephrol 29:1426-1436|
|Sidhu, Rohini; Mikulka, Christina R; Fujiwara, Hideji et al. (2018) A HILIC-MS/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum. Biomed Chromatogr 32:e4235|
|Liu, Hui; Jin, Hongjun; Han, Junbin et al. (2018) Upregulated Sphingosine 1-Phosphate Receptor 1 Expression in Human and Murine Atherosclerotic Plaques. Mol Imaging Biol 20:448-456|
|Wang, Songyan; Oestricker, Lauren Z; Wallendorf, Michael J et al. (2018) Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance. PLoS One 13:e0192441|
|Turk, John; White, Tayleur D; Nelson, Alexander J et al. (2018) iPLA2? and its role in male fertility, neurological disorders, metabolic disorders, and inflammation. Biochim Biophys Acta Mol Cell Biol Lipids :|
Showing the most recent 10 out of 654 publications